|
- Contains clinical cases detailing the uses of biomarkers to define outcomes
- Takes a teaching file approach to establish best practice
- Presents clinical information in a practical manner and includes a wealth of algorithms and explanatory illustrations
This book covers ACS and Heart Failure, the chapters represent the most current, up to date and knowledgeable content on the topic available. It is written by the worlds most respected leaders in biomarkers, with a majority emphasis on what clinicians need to know. The Editors and their contributors have provided algorithms, annotated case discussions and caveats. They cover biomarkers to predict risk of heart disease, biomarkers of cardiorenal disease, and conclude with a section on new and emerging biomarkers. It be genuinely helpful and practical to those in the field, including not just people working in the field, but nurses, doctors, etc who practice medicine in the clinic, the emergency department and the hospital. Table of Contents- Pre-analytical Factors and Analytical Issues Affecting Interpretation of Cardiovascular Biomarkers
- Troponin Basics for Clinicians
- Unique Aspects of High Sensitivity Assays: What Are They, Why Do We Need Them, and How Do We Use Them?
- Evaluation of Patients Presenting with Chest Pain in the Emergency Department: Where Do Troponins Fit In?
- Using Cardiac Troponins in Patients with Acute Myocardial Infarction
- What Is a Type 2 Myocardial Infarction: How Is It Recognized and What Should One Do to Establish That Diagnosis?
- Use of Cardiac Troponin in Patients with Heart Failure
- Elevated cTn in Other Acute Situations Such as Atrial Fibrillation, Sepsis, Respiratory Failure, and Gastrointestinal Bleeding
- Use of cTn for Detection of More Chronic Disease States
- Other Biomarkers in Acute Coronary Syndrome
- Newer Lipid Markers: Apolipoprotein B, LDL Particle Concentration, and Triglyceride-Rich Lipoproteins – When Are They Needed?
- Natriuretic Peptides: Physiology for the Clinician
- Natriuretic Peptides: Basic Analytic Considerations
- Natriuretic Peptide Use in Screening in the Community
- Natriuretic Peptide Use in the Emergency Department
- Heart Failure: Natriuretic Peptide Use in the Hospital
- Natriuretic Peptide Guided Therapy in Outpatient Heart Failure Management
- Caveats Using Natriuretic Peptide Levels
- Gaps in Our Biomarker Armamentarium: What Novel Biomarkers Might Be Synergistic in Patients with Acute Disease
- Biomarkers in Heart Failure: ST2
- Biomarkers in Heart Failure: Procalcitonin
- Novel Biomarkers in Heart Failure: Adrenomedullin and Proenkephalin
- Biomarkers in Specific Disease States: Cardio-Oncology
- Biomarkers in Specific Disease States: Cardio-Oncology
- Biomarkers of Sarcopenia and Mitochondrial Dysfunction
- Biomarkers in Arrhythmias, Sudden Death, and Device Therapy
- Biomarkers in Cardio-Renal Dysfunction
- Biomarkers in Heart Failure with Preserved Ejection Fraction
|
